Cargando…
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
Autores principales: | Nabavi, Seyed Fazel, Habtemariam, Solomon, Sureda, Antoni, Banach, Maciej, Berindan-Neagoe, Ioana, Cismaru, Cosmin Andrei, Bagheri, Mahdi, Bagheri, Mohammad Sadegh, Nabavi, Seyed Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497541/ https://www.ncbi.nlm.nih.gov/pubmed/32950470 http://dx.doi.org/10.1016/j.clinbiochem.2020.09.004 |
Ejemplares similares
-
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020) -
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020) -
Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell
por: Nabavi, Seyed Fazel, et al.
Publicado: (2021)